ӳ��ý

Genomic profile of human meningioma cell lines.

Mei Y, Bi WL, Greenwald NF, et al. Genomic profile of human meningioma cell lines. PLoS One. 2017;12(5):e0178322. doi:10.1371/journal.pone.0178322

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.

Juratli TA, McCabe D, Nayyar N, et al. DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome. Acta Neuropathol. 2018;136(5):779-792. doi:10.1007/s00401-018-1899-7

Meningioma transcription factors link cell lineage with systemic metabolic cues.

Du Z, Brewster R, Merrill PH, et al. Meningioma transcription factors link cell lineage with systemic metabolic cues. Neuro Oncol. 2018;20(10):1331-1343. doi:10.1093/neuonc/noy057

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.

Brastianos PK, Horowitz PM, Santagata S, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013;45(3):285-9. doi:10.1038/ng.2526

ARID1A and TERT promoter mutations in dedifferentiated meningioma.

Abedalthagafi MS, Bi WL, Merrill PH, et al. ARID1A and TERT promoter mutations in dedifferentiated meningioma. Cancer Genet. 2015;208(6):345-50. doi:10.1016/j.cancergen.2015.03.005